Waystar Weighs Sale Amidst Market Pressures, Sources Reveal

Healthcare software provider Waystar is reportedly exploring a range of strategic options, including a potential sale, according to sources familiar with the matter. This comes just two years after the company made its debut on the New York Stock Exchange.

Investment Bank Evercore Advising

Waystar, headquartered in both Lehi, Utah, and Louisville, Kentucky, has engaged investment bank Evercore to guide the exploration process. The discussions are said to be in preliminary stages, and sources caution that a sale is not guaranteed. Waystar and Evercore have both declined to comment on the situation.

The company, which provides software solutions for hospitals and doctors to manage payment processes, has seen its market valuation decrease to approximately $4.8 billion. This decline follows a 24% drop in its share price this year, attributed to a broader downturn in the software sector.

Market Valuation and Investor Concerns

Waystar's strategic positioning as a healthcare software entity, rather than a service-heavy business, was designed to attract the higher valuations typical of tech companies. Initially, this approach was successful, with shares climbing from $20 at the IPO to a high of $45 in 2025. However, recent investor concerns over potential disruptions from advancements in artificial intelligence have exerted downward pressure on the stock, according to a Morgan Stanley report.

The company emerged from the 2017 merger of Zirmed and Navicure, both specialists in healthcare revenue management. Its principal investors, including EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital, took Waystar public in 2024. Current data from LSEG indicates EQT holds a 13% share, CPPIB 10%, and BlackRock Institutional Trust Company 8%.

Potential Sale and Market Implications

As Waystar considers a sale, the process may serve as a barometer for investor appetite within the software sector. The outcome could influence how other companies in similar sectors approach market volatility and strategic pivots.

While EQT and BlackRock have refrained from commenting, CPPIB has yet to respond to inquiries. The industry will be closely watching to see whether Waystar's move signals a broader trend of re-evaluating public market strategies amid fluctuating investor confidence.